Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
Raghavendra Rao, General Surgeon at Vein Clinic, Founder of Best Surgical Education, LLC, shared a post on LinkedIn about a recent article by Maciej Wołkowski et al, published in JVS-VL, adding:
“Concomitant foam sclerotherapy of tributaries after truncal ablation with EVLA results in better varicose vein regression at 3 months in the short term and may result in a better quality of life at 6 months.
This comes at the cost of using too much or too concentrated sclerosant, resulting in foam sclerotherapy complications.
Non-randomized study published recently in JVS-VL.
The controversy continues regarding the need for tributary management after EVLA of the truncal veins, but a good percentage seem to need further treatments.
EVLA does have a substantial effect on tributary varicose veins.”
Title: Clinical trial of concomitant versus staged foam sclerotherapy of varicose veins following axial thermal ablation.
Authors: Maciej Wołkowski, Tomasz Urbanek, Krzysztof Wołkowski, Grzegorz Biolik, Wacław Kuczmik
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention
-
Jul 6, 2026, 19:23Rob Mac Sweeney: Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia
-
Jul 6, 2026, 19:22Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood